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FOXO3a Turns the Tumor Necrosis Factor Receptor
Signaling Towards Apoptosis Through Reciprocal
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Objective—We evaluated the full range effects of FOXO3a in endothelial cells (ECs) by microarray analysis and
investigated the role of FOXO3a regulating TNF receptor signaling pathway.
Methods and Results—Human umbilical vein endothelial cells (HUVECs) were transfected with adenoviral vectors
expressing constitutively active FOXO3a (Ad-TM-FOXO3a). Ad-TM-FOXO3a transfection caused remarkable
apoptosis, which were accompanied with upregulation of genes related with TNF receptor signaling, such as TNF-,
TANK (TRAF-associated NF-B activator), and TTRAP (TRAF and TNF receptor-associated protein). Furthermore,
B-Ras1 (IB-interacting Ras-like protein-1) which is known to block IB degradation was found increased, and
intranuclear translocation of NF-B was inhibited. GADD45 and XIAP, negative regulators of c-Jun N-terminal kinase
(JNK), were suppressed and JNK activity was increased. Attenuation of TNF signaling pathway either by blocking
antibody for TNF receptor or by blocking JNK with DMAP (6-dimethylaminopurine) or Ad-TAM67 (dominant negative
c-Jun) cotransfection, significantly reduced FOXO3a-induced apoptosis. Finally, treatment of vasculature with heat
shock, an activator of endogenous FOXO3a, resulted in EC apoptosis, which was completely rescued by Ad-TAM67.
Conclusion—FOXO3a promotes apoptosis of ECs, through activation of JNK and suppression of NF-B. These data
identify a novel role of FOXO3a to turn TNF receptor signaling to a proapoptotic JNK-dependent pathway. (Arterioscler
Thromb Vasc Biol. 2008;28:112–120.)
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The status of the external environment influences cellsurvival via various signaling mechanisms. Tumor ne-
crosis factor (TNF) is a potent cytokine that serves pleiotropic
function in inflammation, cell proliferation, and apoptosis.1,2
NF-B and c-Jun are known as 2 major transcription factors
mediating the TNF receptor signaling.3 In this cascade,
NF-B plays a dominant role mediating inflammatory re-
sponse while blocking apoptosis via inhibition of the c-Jun-
N-terminal kinase (JNK).4
Forkhead transcription factors are emerging as key factors,
under regulation of Akt, to play various roles ranging from
cellular proliferation, metabolism,5 apoptosis,6,7 and even
adaptation to cellular stress.8,9 Regarding endothelial cells
(ECs), previous studies by our group10,11 and others12 have
suggested a proapoptotic role of FOXO3a, one of main
forkhead transcription factors expressed in ECs. But the
molecular mechanism of FOXO3a in ECs has not been fully
defined yet.
In this study, we evaluated the full range effects of
FOXO3a on human umbilical vein endothelial cells
(HUVECs) by microarray analysis, in which we found that
several genes involved in the TNF receptor pathway were
upregulated. Therefore we investigated the role of FOXO3a
in the TNF receptor signaling and its implication of the
proapoptotic action of FOXO3a in ECs in vitro and in vivo.
Materials and Methods
For expanded methods, please see the supplemental materials,
available online at http://atvb.ahajournals.org.
EC Culture and Gene Transfer Using
Adenoviral Vectors
Four to 6 passage of HUVECs (Clonetics) were cultured as previ-
ously described.13
Oligonucleotide Microarray
Magic-II 10K oligonucleotide microarray (Macrogen) was used as
previously described.10,14
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Real-Time Quantitative RT-PCR Analysis
Changes in RNA-expression of TANK (TRAF-associated NF-B
activator), and TTRAP (TRAF and TNF receptor-associated protein)
were determined by real-time QRT-PCR as previously described.10
RT-PCR and Immunoblot Analysis
Changes in RNA expression of TNF-, B-Ras1, GADD-45, and
XIAP were determined by RT-PCR as previously described.15
Chromatin Immunoprecipitation (ChIP) Assay
A chromatin immunoprecipitation (ChIP) assay was performed.
Immunofluorescent Staining
For NF-B localization, HUVECs were immunostained with mouse
monoclonal antibody against p65.
Immunoprecipitation/In Vitro JNK Kinase Assay
Immunoprecipitated proteins with anti-JNK1 antibody were incu-
bated with anti-phospho-c-jun antibody to compare phosphorylating
activity of JNK1 as previously described.16
Electrophoretic Mobility Shift Assay
The DNA binding activity of the nuclear protein was evaluated
according to the established method with modifications.17
Evaluation of In Vivo Endothelial Denudation and
Apoptosis After Heat Shock Treatment on Vessel
Male Sprague-Dawley rats, 13 weeks old, weighing about 400 g
(Daehan Biolink Co, Chung-Buk, Korea) were used for animal
experiment as previously described.18
FACS Analysis of EC Apoptosis
Apoptosis was quantified by measuring the hypodiploid DNA
content using flow cytometry (FACS) analysis.18
Statistical Analysis
All data are expressed as meanSD.
Results
FOXO3a-Regulated Genes Identified by
Oligonucleotide Microarray
To identify the FOXO3a-regulated genes in ECs, we com-
pared the gene expression profile of Ad-TM-FOXO3a–trans-
fected HUVECs with a control vector (Ad-GFP) or Ad-DN-
FOXO3a-transfected HUVECs. From our previous
experiments, genes transfected by adenoviral vectors are
appreciably expressed approximately 12 hours after transfec-
tion.10 Therefore, we decided to evaluate at 16, 24, and 40
hours to include both early and late response to FOXO3a
activation. The activation or suppression of genes was eval-
uated by measuring the fold ratio between Ad-TM-FOXO3a
or Ad-DN-FOXO3a–transfected HUVECs with Ad-GFP–
transfected HUVECs. A cDNA was considered a putative
FOXO3a-regulated target if the hybridization signal was
more than 2 folds of the control.
Constitutive activation of FOXO3a increased the expres-
sion of 73 genes and decreased 59 genes out of 10 000
genes analyzed. The Table lists some of the genes that were
strongly regulated by FOXO3a. As expected from the previ-
ously reported proapoptotic action of FOXO3a, several genes
associated with apoptosis or cell cycle arrest were upregu-
lated, whereas most of the genes that were significantly
downregulated were those known to be associated with
extracellular matrices, heat shock proteins, and growth fac-
tors (supplemental Figure I, available online at http://atvb.
ahajournals.org). From this data, we found that Fas ligand,
which is a well-known effecter molecule in forkhead tran-
scription factor–induced apoptosis of neural cells and fibro-
blasts,19 was not upregulated in ECs, suggesting that, at least
in ECs, there exists another mechanism which mediates
apoptotic signaling. Interestingly, we found that, in the highly
upregulated genes, there were several genes related to TNF
receptor signaling pathway, including TNF-, TANK,
TTRAP, and B-Ras1 (IB-interacting Ras-like protein-1),
suggestive of a link between FOXO3a and the TNF receptor
signaling.
FOXO3a Induces and Amplifies TNF
Receptor Signaling
To validate the microarray data, we evaluated TANK and
TTRAP mRNAs, which were found to be significantly
upregulated (Figure 1A). The relative fold elevation com-
pared with GAPDH was 10.3 at 16 hours, 12240 at 24
hours, and 293110 at 40 hours in case of TANK, and 10.3
at 16 hours, 18660 at 24 hours, and 29991100 at 40 hours
in case of TTRAP, respectively. Changes of TNF- were
analyzed in 2 ways; the secreted TNF- by ELISA of the cell
culture supernatant and the intracellular TNF- by immuno-
blot of the cell lysates. FOXO3a activation significantly
increased TNF- in both instances (Figure 1B). Immunoblot
analysis confirmed the increased protein synthesis of TANK
and TTRAP, which was completely reversed by Ad-DN-
FOXO3a (Figure 1C). Next, we performed ChIP analysis to
investigate the transcriptional regulation of those molecules
by FOXO3a and found that FOXO3a was bound to the
promoter sites of TANK, whereas was not bound to either
TNF- or TTRAP (Figure 1D), of which pattern was con-
firmed by electrophoretic mobility shift assay using the
putative FOXO3a binding site oligonucleotides (supplemen-
tal Figure II).
FOXO3a Induced B-Ras1, Suppressing
NF-B Activation
B-Ras1 (IB-interacting Ras-like protein-1) is known as an
inhibitor of NF-B by regulating IB degradation.20,21
FOXO3a activation increased B-Ras1 both in mRNA level
(supplemental Figure IIIA) and in protein level (Figure 2A,
upper panel), which was reversed by Ad-DN-FOXO3a. The
increment of B-Ras1 corresponded to the significant in-
crease of IB protein but not to the change of IB amount
(data not shown), which suggested that degradation of IB
was prevented by B-Ras1 (Figure 2A, middle panel). The
ChIP analysis also suggested that B-Ras1 expression was
transcriptionally regulated by FOXO3a (Figure 2C).
Next, NF-B activity in response to FOXO3a overexpres-
sion was evaluated by immunofluorescent staining for p65
subunit of NF-B after 24 hours of adenoviral transfection.
NF-B primarily remained in the cytoplasm either in Ad-GFP
or Ad-TM-FOXO3a transfected HUVECs (Figure 2B, upper
panels). When stimulated with TNF-, a well-known positive
regulator of NF-B, p65 still remained in the cytoplasm in
FOXO3a-transduced ECs, whereas it was swiftly translocated
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Table. FOXO3a-Regulated Genes After Adenoviral Gene Transfer in HUVECs (partial list)
Accession No. Gene Symbol Gene Description TM-16 hr TM-24 hr TM-40 hr DN-16 hr DN-24 hr DN-40 hr Function
NM_016508 CDKL3 Cyclin-dependent
kinase-like 3
93.33 295.1 7.41 Cell cycle
AK128396 TRAF6 TNF receptor-associated
factor 6
35.48 6.46 Signaling
NM_005310 GRB7 Growth factor
receptor-bound protein 7
33.88 10.72 40.74 24.55 3.24 Signaling
NM_003640 IKBKG Inhibitor of kappa light
polypeptide enhancer in B
cells
30.73 0.85 0.33 0.06 Signaling/immune
NM_002423 MMP7 Matrix metalloproteinase
matrilysin uterine
16.70 32.02 32.63 43.65 3.89 Matrix
NM_005527 HSPA1L Heat shock 70kD
protein-like 1
15.14 28.18 Regulation of apoptosis
NM_001334 CTSO Cathepsin O 13.80 47.86 0.95 0.09 Proteolysis/peptidolysis
NM_002422 MMP3 Matrix metalloproteinase 3
(stromelysin 1)
7.06 15.45 4.10 4.30 1.32 8.15 Matrix
NM_000594 TNF Tumor necrosis factor 6.03 4.14 3.01 0.50 0.34 1.32 Signaling
NM_006256 PKN2 Protein kinase N2 6.03 7.84 9.80 1.34 0.43 0.81 Signaling
AK074480 ANXA1 Annexin A1 5.90 8.66 7.90 0.98 0.79 0.75 Intracellular signaling
NM_002425 MMP10 Matrix metalloproteinase 10
(stromelysin 2)
5.87 6.60 4.79 0.19 Matrix/proteolysis
NM_006218 PIK3CA Phosphoinositide
3-kinase, catalytic, alpha,
4.75 5.87 1.05 1.17 Signaling/akt block
NM_015645 CIQTNF5 C1q and tumor necrosis
factor related protein 5
4.66 8.35 0.48 0.40 0.57 1.44 Apoptosis
NM_002838 PTPRC Protein tyrosine
phosphatase, receptor type,
C
4.67 2.14 0.18 0.26 Proliferation
NM_002731 PRKACB Protein kinase,
cAMP-dependent, catalytic,
beta
4.57 4.57 21.38 Signaling
NM_153425 TRADD TNFRSF1A-associated via
death domain
4.32 0.59 0.06 0.39 0.32 0.50 Apoptosis/signaling
NM_020345 KBRAS1 NFKB inhibitor interacting
Ras-like 1
4.27 3.72 35.48 0.34 1.51 Signaling
NM_016614 TTRAP TRAF and TNF
receptor-associated protein
3.23 2.88 3.83 1.08 0.84 0.89 Transcription
NM_004180 TANK TRAF family
member-associated NFKB
activator




0.47 0.37 0.04 0.67 0.59 1.08 Growth/adhesion
NM_183422 TSC-22 Transforming growth factor
beta-stimulated CLONE 22
0.45 0.43 0.17 0.59 0.91 1.44 Transcription
NM_001226 CASP6 Caspase 6,
apoptosis-related cysteine
protease
0.44 0.39 0.10 0.59 2.24 1.62 Apoptosis
NM_001554 CYR61 Cysteine-rich, angiogenic
inducer, 61
0.37 0.16 0.59 0.81 0.71 0.84 Adhesion/proliferation
NM_016292 TRAP1 Heat shock protein 75 0.29 0.05 1.04 6.35 1.41 Regulation of apoptosis
NM_002587 PCDH-1 Protocadherin 1 0.27 0.45 0.28 1.03 1.67 1.41 Adhesion/signaling
NM_006597 HSPA8 Heat shock 70kD protein 8 0.21 0.27 0.04 0.77 0.72 1.12 Regulation of apoptosis
Blank sections are not determined in microarray.
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into the nucleus in the control ECs (Figure 2B, lower panels).
This suppression of NF-B activation by FOXO3a was
confirmed by electrophoretic mobility shift assay, which
showed reduced nuclear translocation of NF-B in TM-
FOXO3a transduced HUVECs (supplemental Figure IIIB).
Because NF-B is reported to regulate JNK via GADD45
and XIAP,22 we evaluated the expression of GADD45 and
XIAP after FOXO3a activation. The expression of
GADD45 and XIAP were significantly downregulated fol-
lowing FOXO3a activation (Figure 2D, supplemental Figure
IIIC).
FOXO3a Activates JNK, Turning TNF Receptor
Pathway Toward Apoptosis
JNK activity after FOXO3a activation was evaluated using an
in vitro kinase assay. Strong activation of JNK was detected
after 24 hours of TM-FOXO3a gene transduction compared
with the control, which was near completely reversed by
Ad-DN-FOXO3a (Figure 3A). Then, the role of the increased
JNK activity on TNF- expression was evaluated. As shown
in Figure 3B, the induction of TNF- expression by FOXO3a
was completely reversed by Ad-TAM67 in ECs under stim-
ulation of lipopolysaccharide (LPS) or heat shock. These
findings indicate that the increased c-Jun after FOXO3a
activation might be the regulatory mechanism of FOXO3a-
induced TNF- expression especially in the activated ECs.
Next, we performed blocking experiments of TNF receptor
signaling pathway to investigate how much TNF receptor
signaling to JNK contributes to proapoptotic action of
FOXO3a. When TNF- signal was inhibited by a blocking
antibody against TNF receptor, FOXO3a-induced apoptosis
was significantly attenuated. Moreover, when JNK was
blocked either by 6-Dimethylaminopurine (DMAP), a JNK
inhibitor, or by cotransfection with Ad-TAM67, apoptosis
was reduced in a similar extent to TNF- receptor blockage
(Figure 3C, supplemental Figure IVA).
To elucidate the implication of native FOXO3a–JNK
signaling during the stress response, HUVECs were subjected
to heat shock at 42°C for 4 hours (supplemental Figure IVB).
In resting state, native FOXO3a located in cytoplasm, thus
remained inactive. Heat shock rapidly induced intranuclear
translocation thus activation of native FOXO3a from 30
minutes, which was accompanied with increased cytotoxicity
(Figure 3D). Transduction with Ad-TAM67 or DN-FOXO3a
significantly reduced cytotoxicity under these conditions,
suggesting the hypothesized FOXO3a - JNK signaling path-
way contributes to the cytotoxicity of ECs during stress
condition.
Figure 1. FOXO3a induces TNF-, TANK, and TTRAP expression. A, Quantification of real-time quantitative RT-PCR using gene-
specific human TANK and TTRAP primers. Data are expressed as meanSE for 3 independent experiments. B, ELISA in supernatant
(upper) and immunoblot of whole cell lysates for TNF- (lower). C, Immunoblot of TANK and TTRAP. D, Chromatin immunoprecipitation
assays of TNF-, TANK, and TTRAP. Those showed FOXO3a bound to the promoter region of TANK, not to the promoter regions of
TNF- or TTRAP.
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In Vivo Evidence of FOXO3a-Induced
JNK-Mediated Endothelial Damage in Heat-Shock
Treated Vessel
Finally, to show that the activation of FOXO3a is a physio-
logically relevant phenomenon, we performed experiments
where rat carotid arteries were exposed to heat shock with or
without prior blockade of FOXO3a signaling by in vivo gene
delivery of the indicated adenoviral vectors. Then, the heat-
shocked vessels in organ culture were immunostained and the
luminal surface of the endothelial lining of the vessel was
observed en face by the confocal microscopy. Double immu-
nostaining of VE-cadherin and activated caspase-3 visualized
apoptosis of ECs on the luminal surface of blood vessel after
heat shock, which was reduced by pretreatment with Ad-
TAM67 and was aggravated by Ad-TM-FOXO3a (Figure
4A). In immunostaining of PECAM-1 with DAPI staining,
we quantitated the endothelial damage by counting the round
nuclei with PECAM-1 positivity as viable ECs on the luminal
surface of vessel (Figure 4B). Heat shock treatment signifi-
cantly reduced the number of viable ECs on luminal surface
of vessel compared with normal temperature control group.
Pretreatment with Ad-TAM67 significantly protected endo-
thelial lining from heat shock-induced damage. Conversely,
pretreatment with Ad-TM-FOXO3a significantly aggravated
damage on the endothelial lining of heat-shocked vessel
(Figure 4C, supplemental Figure VII).
Discussion
The important finding of our study is that the forkhead
transcription factor, FOXO3a, activates JNK, while suppress-
ing NF-B in ECs, which turns the TNF receptor signaling
from survival to apoptosis. In addition, this study has several
Figure 2. FOXO3a induces B-Ras1, leading to suppression of NF-B. A, Immunoblot of the whole cell lysates for B-Ras1 and IB.
B, Immunocytochemistry and fluorescent microscopy for p65 subunit of NF-B. After adenoviral transduction, cells were either
unstimulated or stimulated with TNF- for 45 minutes. In unstimulated state, NF-B was primarily detected in the cytoplasm of
HUVECs transfected with either Ad-GFP or Ad-TM-FOXO3a (upper panels). When stimulated with TNF-, p65 NF-B in the control
group translocate to the nucleus, whereas in TM-FOXO3a transduced HUVECs p65 still remained in the cytoplasm (lower panels). C,
Chromatin immunoprecipitation assays of B-Ras1. D, Immunoblot of whole cell lysates of ECs for GADD45 and XIAP.
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novel findings. First, oligonucleotide microarray showed the
change of the expression of several genes, which had not been
reported to be regulated by FOXO3a previously. We found
that FOXO3a induced TANK, TTRAP, and B-Ras1, which
might be responsible for the activation of JNK as well as
suppression of NF-B. Second, inhibition of TNF receptor–
JNK signaling pathway significantly attenuated the apoptosis
of EC after FOXO3a activation, suggesting that the TNF
receptor signaling lies in downstream of FOXO3a. This study
not only shows that JNK activation and NF-B suppression
are novel mechanism of FOXO3a-induced apoptosis in ECs,
but also provides new insight into the role of FOXO3a in the
TNF receptor signaling.
Finding Putative Genes Mediating
FOXO3a-Induced Apoptosis by
Oligonucleotide Microarray
By using adenoviral gene transfection and the oligonucleotide
microarray, we identified several candidate genes that were
regulated by FOXO3a in ECs. Among them, TNF-, TRAPP,
and TANK are proapoptotic molecules,23–25 of which relation
to the forkhead transcription factors has not been previously
reported. Another molecule upregulated by FOXO3a was
B-Ras1 (IB-interacting Ras-like protein-1), known as an
inhibitor of NF-B activation.20,21 Among them, TANK and
B-Ras1 were found to have the forkhead factor binding
motif, WAARYAAAYW (WA or T, RA or G, YC or
T)26 in their promoter sequences and transcriptionally regu-
lated by FOXO3a. Though TTRAP and TNF- also have
similar motifs in their presumed promoter sequences, their
regulation by FOXO3a was not done at transcriptional level.
FOXO transcription factors can activate 2 different subsets of
genes27,28: (1) genes that require FOXO DNA binding, and,
intriguingly, (2) genes regulated independently of FOXO
DNA binding. For example of first category, TANK and
B-Ras1 gene expression in our study were transcriptionally
regulated by direct binding of FOXO3a in its promoter
region. For genes of secondary category, FOXO transcription
factors can cooperate with other additional transcription
factors to activate transcription of genes. This second mech-
Figure 3. FOXO3a activates JNK, turning TNF receptor pathway toward apoptosis. A, Immunoprecipitation/Kinase assay for JNK activ-
ity. c-jun N-terminal phosphorylation activities determined by in vitro kinase assay. B, ELISA in supernatant (upper) and RT-PCR of
whole cell lysates for TNF- (lower). C, A bar graph of apoptotic FACS analysis counting hypodiploid cells. HUVECs were cultured in
the presence of serum for 24 hours after transduction with indicated adenoviral vectors or designated blocking agents. TNF- R Ab,
neutralizing antibody of TNF receptor; DMAP, 6-Dimethylaminopurine; Ad-TAM67, adenoviral vector expressing a dominant negative
c-Jun mutant. (*P0.05 compared with Ad-GFP, n3). D, Trypan blue exclusion assay evaluating HUVEC viability after 4 hours of heat
incubation with indicative adenoviral transfection. Results are expressed as the meanSEM of triplicate assay (*P0.05, n3).
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anism may explain the discrepancy between the increased
protein level in immunoblot analysis and absence of
FOXO3a-DNA binding in ChIP analysis observed in cases of
TTRAP and TNF-.
Relevance of the TNF Receptor Signaling in
FOXO3a-Induced Apoptosis
Because TNF-, TRAPP, TANK, and B-Ras1 are all known
to be related with either JNK or NF-B, the 2 main down-
stream molecules of the TNF receptor pathway, we hypoth-
esized that the TNF receptor pathway might mediate the
proapoptotic action of FOXO3a. Indeed, blocking either TNF
receptor or JNK significantly reduced apoptosis after
FOXO3a activation. Because TNF receptor pathway is re-
ported to be important in inflammation as well as apoptosis,29
the finding of this study might extend the role of forkhead
transcription factor from as a downstream molecule of Akt6 to
as a upstream molecule pivoting TNF receptor signaling.
TNF- does not induce apoptosis unless the expression of
cytoprotective genes, especially NF-B, is blocked, because
NF-B inhibits JNK activation by TNF-.30–32 However,
when NF-B is suppressed or JNK is activated, as in the case
of FOXO3a activation, the TNF receptor signaling shifts the
fate of the cells from survival toward apoptosis. Here, we
showed that FOXO3a activation inhibited NF-B activation
while activating JNK.
Suppression of NF-B by FOXO3a
Inhibition of NF-B by IB family proteins is an important
mechanism of NF-B regulation. In the resting state, NF-B
p50/p65 dimers are bound to the inhibitor proteins IB and
IB, thus remained inactive.33,34 Among 2 IB proteins,
IB is known to play a critical role isolating NF-B
exclusively in the cytoplasm.20 B-Ras proteins have been
identified as inhibitors of NF-B activation by preventing
IB degradation while having no effect on IB.21 We
found FOXO3a induces B-Ras1, thus inhibiting NF-B.
Considering our findings with a recent report that IB kinase
conversely inhibits FOXO3a and serves as a negative regu-
lator,35 it appears that a short negative feedback loop exists
between FOXO3a and NF-B.
Role of FOXO3a in Activation of JNK
Signal transduction in the TNF receptor pathway involves
several regulatory factors. Most of these proteins have been
identified as TRAF-binding proteins, eg, TTRAP and TANK.
Overexpression of these factors either inhibits TRAF-
mediated activation of NF-B or potentiates TRAF-mediated
Figure 4. In vivo pathophysiologic significance of FOXO3a in heat shock treated blood vessel. A, Confocal microscopic en face view of
luminal surface of blood vessels immunostained with antibodies against VE-cadherin and activated caspase-3 with DAPI. White arrows
indicate apoptotic endothelial cells. B, Confocal microscopic en face view of luminal surface of blood vessels immunostained with anti-
body against PECAM-1 plus DAPI before and after heat shock treatment. Viable ECs are PECAM-1 positive (red) cells with round
nucleus. In contrast, vascular smooth muscle cells below endothelium are PECAM-1 negative cells with elongated nucleus. C, Quanti-
tative data of viable ECs on luminal surface of blood vessels.
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activation of JNK. TANK is reported to be a regulatory
molecule potentiating both NF-B and JNK, thus amplifying
TNF receptor signaling.25 On the other hand, TTRAP is
known to inhibit NF-B in a dose-dependent and stimulus-
dependent manner,24 thus turning TNF receptor pathway
signals to JNK activation. This fits in with the results of the
present study, where both TANK and TTRAP were found to
be upregulated by FOXO3a activation. Taken together, ex-
pression of not only TANK but also TTRAP after FOXO3a
activation may not only potentiate but also turn TNF receptor
pathway signals toward JNK. Another regulating mechanism
of JNK by NF-B is through GADD45 and XIAP.22 In our
study, GADD45 and XIAP expression was found to be
decreased after FOXO3a activation, which could also result
in JNK activation. We do not make any conclusion on
whether induction of TANK and TTRAP or attenuation of
GADD45 and XIAP plays a major role in activation of JNK
by FOXO3a. However, we think it is important that activation
of FOXO3a results, at the end, in an overall increase in JNK
activity, resulting in EC apoptosis. To the best of our
knowledge, activation of JNK by forkhead transcription
factors is a novel finding which has not been previously
reported.
In Vivo Pathophysiologic Significance of
FOXO3a-Induced Endothelial Damage
Using in vivo animal experiment, we confirmed in vivo
pathophysiologic significance of FOXO3a-induced JNK-
medicated endothelial damage in heat shock–treated rat
carotid artery. In this experiment, we demonstrated that heat
shock, an activator of endogenous FOXO3a, significantly
induced endothelial damage, and that such damage was
completely prevented by pretreatment of Ad-TAM67
(dominant-negative c-jun). These findings suggest that patho-
physiologic stress like heat shock may induce FOXO3a and
JNK, leading to endothelial damage and vasculopathy.
Conclusion
As summarized in Figure 5, our study demonstrates that
FOXO3a plays a pivotal role in switching the TNF receptor
pathway toward apoptosis by suppressing NF-B and acti-
vating c-Jun. This novel finding provides insight into endo-
thelial signaling of TNF receptor pathway regulated by
FOXO3a.
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